Clinical trial

Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and…

NCT02375204 · Alliance for Clinical Trials in Oncology, Other · Active, not recruiting

Key facts

NCT number NCT02375204
Title Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients with Relapsed or Refractory Germ Cell Tumors
Official title A Randomized Phase III Trial Comparing Conventional-Dose Chemotherapy Using Paclitaxel, Ifosfamide, and Cisplatin (TIP) with High-Dose Chemotherapy Using Mobilizing Paclitaxel Plus Ifosfamide Followed by High-Dose Carboplatin and Etoposide (TI-CE) As First Salvage Treatment in Relapsed or Refractory…
Lead sponsor Alliance for Clinical Trials in Oncology, Other
Collaborators National Cancer Institute (NCI) NIH European Organisation for Research and Treatment of Cancer - EORTC Movember Foundation Institute of Cancer Research (ICR), United Kingdom Cancer Research UK…
Status Active, not recruiting
Phase Phase 3
Study type Interventional
Conditions Germ Cell Tumor, Teratoma, Choriocarcinoma, Germinoma, Mixed Germ Cell Tumor, Yolk Sac Tumor, Childhood Teratoma, Malignant Germ Cell Neoplasm, Extragonadal Seminoma, Non-seminomatous Germ Cell Tumor and 1 more
Intervention type Drug, Procedure
Interventions paclitaxel, ifosfamide, cisplatin, pegylated G-CSF, G-CSF, carboplatin, etoposide phosphate, stem cell reinfusion
Enrollment 420
Start date Aug 6, 2015
Primary completion Jun 1, 2031
Completion Jun 1, 2031
First posted Mar 2, 2015
Last update posted Jan 13, 2025
Countries Australia, Belgium, Denmark, France, Germany, Ireland, Italy, Netherlands, Spain, Switzerland, United Kingdom, United States

At a glance

  • 100–999 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies